← Back to headlines
NeOnc Reports Successful Phase 2A Clinical Trial Results
NeOnc announced promising outcomes from its Phase 2A clinical study, suggesting the therapy could pave the way for broader development and significant advancements in oncology treatments.
28 Aug, 14:07 — 28 Aug, 14:07
Sources
Showing 1 of 1 sources


